PLOD2 and colorectal carcinoma: This demonstrated that both of the CRC cell lines in which the Wnt/β-catenin pathway was activated by different mutations [β-catenin in LS 174T and adenomatous polyposis coli (APC) in DLD1] displayed an increase in PLOD2 upon L1 overexpression.